Headlines

заголовки анонсы
06.11.2026
17:15 Bioengineer.org Crotonylation Boost Keeps Aging Stem Cells Fighting Gut Inflammation

Researchers report that restoring the chemical tag lysine crotonylation through sodium crotonate rejuvenates aging adipose-derived stem cells and improves their anti-inflammatory performance in a mouse model of colitis.

Скрыть анонс
16:39 Bioengineer.org Transient Growth Regulator Flooding Enhances Direct Shoot Regeneration in Stubborn Grain Legumes

A transient thidiazuron flooding protocol stimulates high-frequency direct shoot regeneration across four recalcitrant grain legume species without producing visible intermediate callus.

Скрыть анонс
16:03 Bioengineer.org Nanopit Arrays Outperform Nanopillars in Promoting Stem Cell Spreading and Osteogenesis

Nanopit arrays promote greater cell spreading, focal adhesion maturation, and early osteogenic RUNX2 expression in human adipose-derived stem cells compared to nanopillar arrays.

Скрыть анонс
15:29 CNBC top news Could CRISPR cure rare diseases before birth? Scientists are getting closer

Researchers are exploring fetal gene editing to treat rare genetic disorders before they cause lasting damage.

Скрыть анонс
15:27 Bioengineer.org Tanzania’s first UDOM health conference maps progress and gaps from maternal care to kidney transplants

The first University of Dodoma scientific conference on health compiled research showing major gains in maternal survival and kidney transplantation alongside persistent gaps in diabetes control, postnatal care and health system infrastructure across Tanzania.

Скрыть анонс
14:15 FightAging.org Cellular Senescence in Fatty Liver Disease

Fatty liver disease, or at least the non-alcohol induced side of fatty liver disease, more properly known as metabolic dysfunction-associated steatotic liver disease (MASLD) is largely an outcome of obesity. Obesity is now known to promote an accelerated age-related accumulation of senescent cells in many tissues. It is not surprising to find cellular senescence in liver cells as an important mechanism in the progression of MASLD to more severe and ultimately fatal liver conditions. Treating the consequences of obesity with senotherapeutics does not appear a priority for the research and development community, but in fairness a great many more severe conditions have not yet made it onto that still short priority list either. There are only so many researchers and entrepreneurs in the field, and […]

Скрыть анонс
13:59 Arxiv.org CS Adaptive Semantic Branching: Disagreement-Localized Cross-Trajectory Regeneration for Reasoning Candidate Expansion

arXiv:2611.07918v1 Announce Type: new Abstract: Reasoning trajectories generated for the same problem often arrive at conflicting answers. These disagreements reveal alternative intermediate decisions that can be reused to explore new solutions. We introduce Adaptive Semantic Branching (ASB), a training-free inference procedure that turns cross-trajectory disagreement into targeted candidate generation. ASB first groups independently sampled trajectories by extracted final answer, selects a representative from each group, and aligns their reasoning steps with a monotonic dynamic program. A persistent-divergence objective identifies the point at which initially similar reasoning paths develop different continuations. For each selected directed pair, ASB retains the source trajectory's textual prefix, extracts a short reasoning window from a competing donor trajectory, and generates a fresh solution conditioned on both. A diversity-aware policy allocates up to three additional

Скрыть анонс
13:57 Bioengineer.org Researchers Outline Key Considerations for Designing CRISPR-Based Epigenetic Editing Experiments

A review in Clinical Epigenetics outlines experimental considerations and unresolved challenges for designing CRISPR-dCas9 epigenetic editing studies.

Скрыть анонс
12:48 News-Medical.Net Doctors take minutes to measure heart function. AI takes seconds

The study indicates AI can enhance cardiac MRI analysis and mortality prediction, yet its clinical benefits and cost-effectiveness need further investigation.

Скрыть анонс
11:14 Day.Az Hazırda 50-dən çox şəxs ürək transplantasiyası üçün gözləyir

Hazırda 50-dən çox şəxs ürək transplantasiyası üçün gözləyir. Day.Az Trend-ə istinadən xəbər verir ki, bu barədə cümə günü ürək-damar cərrahı Kamran Musayev Ürək Transplantasiyası Həftəsi çərçivəsində Səhiyyə Nazirliyi tərəfindən media nümayəndələri üçün təşkil edilən seminarda çıxışı zamanı deyib.

Скрыть анонс
10:59 Bioengineer.org Reactive oxygen species act as dual regulators of organ regeneration

A new review describes how reactive oxygen species promote regeneration at physiological levels but inhibit it at pathological concentrations.

Скрыть анонс
10:41 Bioengineer.org Umbria’s water mills reframed as territorial infrastructure for multifunctional regeneration

A new study in Built Heritage proposes an analytical framework that treats Umbria's water mills as nodes of a historical territorial energy system and identifies paradigmatic models for their multifunctional regeneration.

Скрыть анонс
09:32 Bioengineer.org Rubidium chloride ultracentrifugation resolves and quantifies dual-AAV gene therapy vectors

A density gradient equilibrium analytical ultracentrifugation method using rubidium chloride achieved high-resolution separation and accurate quantification of the two highly similar full capsids in dual-AAV drug products.

Скрыть анонс
08:58 Bioengineer.org Global liver transplant study finds recipient health and hospital volume outweigh donor factors

An international analysis of 5218 liver transplant recipients across 61 centres shows that recipient characteristics, cold ischaemia time and centre volume predict survival, while donor factors have a minor impact.

Скрыть анонс
08:58 Bioengineer.org CSF cytology endures as AI and telecytology reshape spinal fluid diagnostics

A comprehensive expert review concludes that manual chamber counting and microscopic examination remain the gold standards for cerebrospinal fluid cytology, while artificial intelligence and telecytology require validated workflows before routine adoption.

Скрыть анонс
08:58 Bioengineer.org Topoisomerase TOP2A Keeps Stem Cells Young by Guarding Lamin B1 and Heterochromatin

A new study in Aging Cell shows that the DNA-remodeling enzyme TOP2A sustains Lamin B1 expression to preserve heterochromatin, and that its loss drives senescence in human mesenchymal stem cells and aging-like changes in mouse brain.

Скрыть анонс
08:06 Bioengineer.org CRISPR Test Promises Point-of-Care Diagnosis for Sleeping Sickness

A new review highlights how CRISPR-based SHERLOCK diagnostics could bring rapid, highly sensitive testing for African trypanosomiases to remote clinics.

Скрыть анонс
06:06 Bioengineer.org Lab-grown glioblastoma stem cells reveal how tumors evolve treatment resistance

A new ex vivo platform derives temozolomide- and radiation-selected glioblastoma stem-like cells from the same primary tumor, exposing mismatch-repair loss, drug tolerance, adaptive DNA damage response and receptor tyrosine kinase remodeling as distinct resistance routes.

Скрыть анонс
05:53 KoreaTimes.co.kr SK Biopharmaceuticals builds massive AI dataset to speed up drug discovery

SK Biopharmaceuticals, a Korean firm focused on developing original prescription drugs, has built a massive artificial intelligence (AI) dataset of more than 7 million chemical entries to streamline candidate screening for new therapies. The project is part of the Ministry of Science and ICT’s program to develop AI foundation models for specific fields. A foundation model is a large AI model trained on vast amounts of data that can be adapted for many tasks. SK Biopharmaceuticals belongs to a medical and health care consortium led by medical AI firm Lunit, along with Trillion Labs, Kakao Healthcare and other companies, universities and hospitals. The consortium built a base model specialized in medical science. It then developed versions focused on three areas: drug development, covering chemical compounds and proteins; omics, the large-scale study of genes and other biological molecules; and clinical research. SK Biopharmaceuticals put together the drug discovery dataset based on what

Скрыть анонс
05:13 Bioengineer.org Mediterranean diet shows no significant protection against prostate cancer in meta-analysis

A meta-analysis of fourteen observational studies found no statistically significant difference in prostate cancer risk between men with high and low Mediterranean diet adherence.

Скрыть анонс
04:56 Bioengineer.org Black Soldier Fly Strains Shrug Off Inbreeding, but Longevity Pays the Price

Acute full-sib mating in a black soldier fly strain colonized for over 64 generations caused no production collapse, but inbred adults lived shorter lives and larvae used feed less efficiently.

Скрыть анонс
04:38 Bioengineer.org Quantum Internet Gains a No-Cloning Twist on MIMO Diversity Through Spatial Path Superposition

Researchers propose spatial path superposition, a no-cloning-compatible analogue of MIMO spatial diversity in which a quantum carrier is coherently delocalized over multiple links, enhancing fidelity and generating entanglement during propagation.

Скрыть анонс
03:44 News-Medical.Net The Mediterranean diet has a modern problem, and it isn't just about food

A narrative review published in Applied Sciences examined how urbanisation, time constraints, food costs, and changing lifestyles have contributed to declining adherence to the Mediterranean diet. Drawing on 116 references, the authors identified workplace and school interventions, nutrition education, physical activity, and Mediterranean-inspired convenience foods as potential strategies for adapting this dietary pattern to modern life.

Скрыть анонс
03:09 Bioengineer.org Low-oxygen conditioning of transplant recipients extends heart graft survival in mice

A mouse study finds that conditioning transplant recipients, not donors, under chronic hypoxia prolongs heart allograft survival through a HIF2-dependent shift in circulating monocytes.

Скрыть анонс
03:03 GenEngNews.com Beyond Conventional CRISPR

Genome editing is not designed to replace neurons or retinal cells that have already been lost. In this article, experts from four companies—eGenesis, Epicrispr, KOMO Biosciences, and Sumitomo Pharma America—discuss how they are moving beyond conventional CRISPR to develop novel approaches for treating disease. The post Beyond Conventional CRISPR appeared first on GEN - Genetic Engineering and Biotechnology News.

Скрыть анонс
03:03 GenEngNews.com Tissue Engineering Takes Shape

Personalized grafts, bioinks, and off-the-shelf tissues are advancing regenerative medicine toward broader clinical use. The post Tissue Engineering Takes Shape appeared first on GEN - Genetic Engineering and Biotechnology News.

Скрыть анонс
03:03 GenEngNews.com Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline Expansion

The nonprofit biotech evaluates potential therapies based on unmet medical need, clinical evidence of safety and efficacy, and the compatibility of institutional partners. Its funding model combines initial seed investment with commercial revenue and non-traditional funding sources. The post Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline Expansion appeared first on GEN - Genetic Engineering and Biotechnology News.

Скрыть анонс
02:16 Bioengineer.org Human Umbilical Cord Stem Cells Repair Chronic Liver Injury in Rats by Reshaping Metabolism

A rat study reports that intravenous human umbilical cord mesenchymal stem cells improved liver function, reduced steatosis and fibrosis, and shifted serum metabolites linked to propanoate metabolism.

Скрыть анонс
01:58 Bioengineer.org Senescent Cells May Hold the Key to Chronic Skin Inflammation, Review Finds

A new review argues that senescent cells and their inflammatory secretions may sustain chronic skin inflammation, with the strongest evidence in chronic and diabetic wounds and largely associative findings in psoriasis, atopic dermatitis, lupus, scleroderma, and vitiligo.

Скрыть анонс
01:40 Bioengineer.org Scientists Map How Genome Editing Could Arm Rice Against Drought, Salt and Heat

A new review outlines how CRISPR-based tools are being used to modify stress-responsive genes in rice and what still limits their use.

Скрыть анонс
01:03 Bioengineer.org Seven Ethical Criteria Proposed to Guide Basic Stem Cell-Related Research

Bioethicist Jeremy Sugarman has outlined a seven-criterion ethical framework to guide the assessment, oversight, and conduct of basic stem cell-related research.

Скрыть анонс
00:09 Bioengineer.org Lab-grown gallbladder cancer organoids reproduce tumor genetics and predict chemotherapy response

Patient-derived gallbladder cancer organoids faithfully reproduced tumor genetics and showed drug sensitivities that tracked with patient survival in a preliminary analysis.

Скрыть анонс
05.11.2026
23:50 Bioengineer.org Everolimus, Not Tacrolimus, Let CAR T Cells Erase Relapsed Lymphoma in a Transplant Patient

A case report describes how calcineurin inhibitor-free, mTOR-based immunosuppression enabled successful CD19 CAR T-cell therapy in a kidney-pancreas transplant recipient with relapsed post-transplant lymphoproliferative disorder.

Скрыть анонс
23:50 Bioengineer.org AI-designed CAR binders push cancer stem cell immunotherapy toward safer targets

A new review maps how artificial intelligence could overcome resistance and safety barriers in cancer stem cell-targeted cellular immunotherapy, while stressing that most applications remain computational or preclinical.

Скрыть анонс
23:14 MedicalXpress.com New study warns of dangers behind AI chatbots and 'concerning' health advice from private clinics

AI chatbots are directing users to potentially misleading health information pushed by private medical providers, according to a new Simon Fraser University study published in BMJ Connections Digital Health & AI.

Скрыть анонс
22:37 MedicalXpress.com When doctors and AI medical opinions diverge, humans must question the difference, according to experts

The human doctor and the artificial intelligence (AI) tool they are using more and more frequently are not always going to agree.

Скрыть анонс
22:37 News-Medical.Net CIRM grant funds new stem cell therapy to heal hearts

A new $6.9 million grant from the California Institute for Regenerative Medicine (CIRM) will support preclinical development of an investigational cell therapy for the heart created by USC Stem Cell scientists.

Скрыть анонс
22:33 MorningAgClips.com NRCS Offers Additional Practices for Maryland Farmers Participating in the Regenerative Pilot Program

WASHINGTON — The U.S. Department of Agriculture (USDA) in Maryland has announced additional eligible practices for farmers participating in the Regenerative Pilot Program in fiscal year 2027, providing local agricultural producers with more opportunities to adopt conservation systems that improve soil health, water quality, and long-term farm resilience. Producers can now apply for assistance with […] The post NRCS Offers Additional Practices for Maryland Farmers Participating in the Regenerative Pilot Program appeared first on Morning Ag Clips.

Скрыть анонс
21:25 Bioengineer.org Nerves and Mesodermal Cells Drive Segment Regeneration in Polychaete Annelids

A new review concludes that segment regeneration in polychaete annelids depends on both mesodermal regeneration cells and regenerating nerve fibres acting on the segment addition zone.

Скрыть анонс
21:25 Bioengineer.org CRISPR cuts at wheat centromeres rewrite the karyotype in a single generation

Targeting CRISPR–Cas9 at centromeric retrotransposons in hexaploid bread wheat reconfigured up to 11 chromosomes in a single generation, yielding translocations, isochromosomes and aneuploids.

Скрыть анонс
20:47 Bioengineer.org Dual-branch AI network cleans wearable ECG signals while protecting diagnostic heart waves

Researchers report a dual-branch gated U-Net that removes motion artifacts from wearable ECG recordings while measurably preserving P and T wave morphology.

Скрыть анонс
20:47 Bioengineer.org Primary care visits after kidney transplant linked to better cholesterol control

A retrospective study of 815 kidney transplant recipients found that primary care visits were associated with improved LDL cholesterol control and statin prescription, though not with mortality, hospitalization, or graft failure.

Скрыть анонс
17:07 Endpts.com Ellipsis Health buys Kouper Health to act on AI voice calls

Ellipsis Health, a startup developing voice AI for healthcare, has acquired another company as demand for AI that can call patients heats up, Endpoints News learned exclusively. Ellipsis, which uses voice AI to screen and ...

Скрыть анонс
16:14 Wired.com Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work

Potential Sciences, a startup backed by the UK government, is betting that training AI models on computer-generated biochemical data can speed up the plodding process of developing new drugs.

Скрыть анонс
14:42 FightAging.org Hormone Replacement Therapy Exhibits a Complex Relationship with Aging Clocks

Hormone replacement therapy is a popular treatment for women leading up to or following menopause. Manipulating sex hormones is a very blunt strategy, with potentially significant downsides, and a high variation in outcomes between patients, but the medical community has accumulated a great deal of experience in delivering this class of therapy. In the matter of assessing how this sort of approach affects aging, the research community is presently engaged in a process of gathering as much data as possible on how aging clocks interact with various therapies thought to influence aging or age-related disease. The accuracy of the clocks in the environment of any given therapy is unknown, and the effect of the therapy on the clock is unknown, and so the way forward […]

Скрыть анонс
14:35 TomsHardware.com Anthropic loosens Claude's game cloning ban — AI will now offer to build original games in the requested genre

The update is expected to reduce false positives and allow game developers to use the tool for their own legitimate projects without getting blocked.

Скрыть анонс
14:24 FightAging.org Senescent Cells Promote Senescence in Other Cells in Part via Small Extracellular Vesicle Secretion

It is by now well established that senescent cells promote senescence in neighboring cells. This is a useful and necessary part of the benefits of the transient presence of senescent cells in the contexts of cancer suppression and coordination of wound healing. But when senescent cell clearance falters in later life, and senescent cells begin to linger and accumulate, this promotion of further senescence makes matters worse. One of the ways in which senescent cells promote senescence is via relatively well mapped and well understood inflammatory signaling. Here, however, researchers note that there are other pathways involved, in which the signaling involves the contents of small extracellular vesicles. Interfering in senescent cell signaling as a basis for therapy is likely a more challenging path forward […]

Скрыть анонс
09:30 Technology.org How AI Voice Cloning Is Changing Vishing, and What the Latest Data Shows

Voice phishing, or vishing, used to depend on a convincing script and a confident caller. In 2026 it

Скрыть анонс
09:29 Arxiv.org CS Towards Multi-Method Evaluation of AI in Health: Integrating Benchmarks, Autoraters, and Expert Evaluation

arXiv:2611.05127v2 Announce Type: replace Abstract: General-purpose generative AI (GenAI) models are being rapidly adopted in healthcare, but they are challenging to assess with traditional evaluation frameworks. These conceptual, methodological, and practical challenges parallel decades of work in evaluating clinician and health system quality and safety. We describe the adaptation of methods from several fields, combined with emerging technical approaches, into a structured, multi-method evaluation framework designed to give well-rounded assessments of GenAI in health at scale. The approach first anchors evaluation to Critical User Journeys (CUJs) to help prioritize out of a large choice space, and maps these to a phased AI system lifecycle (base model development, product development, and post-deployment monitoring), since evaluation at each stage requires different methodological approaches. In this context, the approach then integrates three distinct evaluation methods

Скрыть анонс
09:29 Arxiv.org CS Signals: Continuous Diagnostics of AI Agents

arXiv:2611.04507v2 Announce Type: replace Abstract: AI agents can make incorrect decisions or waste resources even when their tools and infrastructure work normally. Their nondeterministic behavior makes these problems difficult to reproduce and diagnose. We developed Signals to identify such problems from agentic traces and suggest concrete remediations. We built the method around a taxonomy of 45 problem types across eight families, with definitions and evidence requirements for each type. The method distinguishes realized failures, risk exposures, and inefficiencies, groups related findings into engineering issues called Signals, and assesses their severity from the supporting evidence. Each Signal includes actions a developer can take and checks for evaluating the change. Further executions can add evidence to an existing Signal or reveal a new problem. We evaluated the method on public agent executions and achieved 91.43% F1 when matching Signals to reference issues, about 18

Скрыть анонс
09:29 Arxiv.org CS Spatial Path Superposition: A No-Cloning Perspective on MIMO-Inspired Spatial Diversity

arXiv:2611.06306v1 Announce Type: cross Abstract: Spatial diversity is a key mechanism in classical Multi-Input Multi-Output (MIMO) communications, where multiple propagation alternatives provide redundant observations that improve reliability in noisy environments. A direct translation of this principle to quantum communications is forbidden by the no-cloning theorem, since an unknown quantum state cannot be copied and transmitted through independent links. In this Perspective article, we argue that spatial path superposition provides a no-cloning-compatible analogue of the spatial-diversity principle of MIMO. Rather than duplicating the transmitted quantum state, a quantum carrier is coherently delocalized over multiple communication links, so that alternative spatial evolutions are experienced in quantum superposition. In this framework, classical redundancy is replaced by spatial coherence, and the communication link itself becomes part of the quantum dynamics. Indeed, spatial

Скрыть анонс
09:29 Arxiv.org CS Multi-Resident Data Association in Smart Homes via MDP Modeling and Behavior Cloning

arXiv:2611.06296v1 Announce Type: new Abstract: Ambient sensors offer a privacy-preserving solution for activity recognition in smart homes, yet they face a critical challenge in multi-resident environments known as Data Association, which aims to identify the resident triggering a specific anonymous sensor event. Existing approaches fundamentally fail to maintain global consistency by often yielding conflicting associations for silent residents. Additionally, these methods frequently suffer from severe trajectory fragmentation caused by the ontological mismatch of applying continuous physical motion models to discrete logical behaviors. To address these limitations, we propose a novel framework that reformulates data association as a sequential decision-making task within a Markov Decision Process (MDP). We solve the defined MDP via Behavior Cloning (BC) to avoid complex reward engineering by directly learning from expert demonstrations. We instantiate the policy using two

Скрыть анонс
09:29 Arxiv.org CS 3D Banff Glomerulitis Scoring for Kidney Transplant Pathology: Feasibility Study for Volumetric Quantification

arXiv:2611.05925v1 Announce Type: new Abstract: Quantifying glomerular inflammation in kidney-transplant biopsies is traditionally performed on single whole-slide sections using the Banff "most-severe section" rule, despite the inherently three-dimensional nature of lesion distribution. This 2D based assessment might lead to instability when inflammation varies across slices. This paper reports a feasibility study examining the technical feasibility and clinical relevance of extending Banff scoring into three dimensions. To this end, we propose a 3D Banff lesion-scoring framework that aligns serial sections, reconstructs glomerular identities across depth, and integrates inflammatory-cell counts in 3D under three scoring strategies: Compatible, Volumetric, and Deduplicated Volumetric. In the experiments, glomerulitis (g-scores) was used as an example Banff metric and applied to multi-section renal allograft biopsies. Our findings indicate that 3D Banff g-scores are more consistent

Скрыть анонс
09:29 Arxiv.org CS VIPBench: A Human-Aligned Benchmark for Voice Identity Perception in the Age of Voice Cloning

arXiv:2611.05638v1 Announce Type: new Abstract: Speaker-recognition benchmarks test how accurately a model recovers the speaker label of a recording, treating voice identity as a property of the person who produced it. However, these benchmarks do not evaluate how humans perceive voice identity. Whether a listener hears two voices as the same person has consequences for intellectual property rights, cybersecurity, and everyday life. We introduce the Voice Identity Perception benchmark (VIPBench), which contains 124,876 same-or-different judgments from 1,290 listeners on 9,800 recording pairs from 100 public figures. The pairs include real recordings, voice clones generated by a text-to-speech system, and morphs between two speakers' voices. We also define four tasks that evaluate the alignment between speaker-representation models and human identity perception. The first two tasks measure how well a model's similarity score predicts the proportion of listeners who respond "same" and

Скрыть анонс
07:37 SingularityHub.Com Microsoft’s Medical AI Is Over Twice as Good Diagnosing Diseases as Doctors

The system, MAI-DxO, was not only more accurate, but it also spent much less on tests to make its diagnoses. The post Microsoft’s Medical AI Is Over Twice as Good Diagnosing Diseases as Doctors appeared first on SingularityHub.

Скрыть анонс
07:22 News-Medical.Net UCLA advances CRISPR gene-editing therapy for sickle cell disease

A UCLA-led team has described how they advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell therapy that can be manufactured at the scale and quality required for a clinical trial.

Скрыть анонс
04:56 GenEngNews.com Rethinking the Clone-First Paradigm for First-in-Human Biologics

A stable-pool strategy can move cell line development off the critical path to Phase I while preserving a path to a conventional clonal cell line as a program matures. The post Rethinking the Clone-First Paradigm for First-in-Human Biologics appeared first on GEN - Genetic Engineering and Biotechnology News.

Скрыть анонс
04:56 GenEngNews.com Gene That Preserves Bone Stem Cell Supply Throughout Life Identified

Researchers found that the gene preserves bone stem cell supply throughout life, and say the discovery advances understanding of stem cell biology and could indicate potential therapeutic approaches to improve bone healing and regeneration in aging and disease. The post Gene That Preserves Bone Stem Cell Supply Throughout Life Identified appeared first on GEN - Genetic Engineering and Biotechnology News.

Скрыть анонс
03:17 TechMeme.com Sources: Google DeepMind spinout Isomorphic Labs is in talks to raise ~$5B at a ~$50B valuation; the AI drug discovery startup last raised $2.1B in May (Bloomberg)

Bloomberg: Sources: Google DeepMind spinout Isomorphic Labs is in talks to raise ~$5B at a ~$50B valuation; the AI drug discovery startup last raised $2.1B in May  —  Alphabet Inc.'s Isomorphic Labs is in talks to raise roughly $5 billion in new funds to support its efforts to use artificial intelligence …

Скрыть анонс
02:22 MedicalXpress.com How a CRISPR sickle cell therapy moved from lab to clinical trial

A UCLA-led team has described how it advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell therapy that can be manufactured at the scale and quality required for a clinical trial.

Скрыть анонс
02:13 Nature.com (news) Epileptic seizures nearly vanish after people receive experimental gene therapy in their brains

Скрыть анонс
02:01 Nature.Com Epileptic seizures nearly vanish after people receive experimental gene therapy in their brains

Скрыть анонс
01:27 Bioengineer.org TACMONO-XL trial to test whether tacrolimus monotherapy can cut infections in older kidney transplant recipients

A new study protocol details the TACMONO-XL trial, which will randomize 306 kidney transplant recipients aged 60 and older to tacrolimus monotherapy or standard triple immunosuppression to test effects on infection-related death and quality of life.

Скрыть анонс
04.11.2026
23:55 Bioengineer.org Engineered Bacteria Pill Cuts Bloodstream Infections in Stem Cell Transplant Patients

A phase 1 trial found that a pill of 16 selected beneficial bacteria was safe for stem cell transplant patients and was associated with fewer bloodstream infections.

Скрыть анонс
23:36 Bioengineer.org Lab-grown blood vessel model lets researchers test stents under real flow

Researchers built a cell-lined silicone blood vessel large enough to hold a real stent and quantified how endothelial cells recolonize the device under controlled blood-flow conditions.

Скрыть анонс
23:18 Endpts.com Kamau shares first data from revamped sickle cell gene editing therapy

Kamau Therapeutics, which has stayed relatively quiet since its 2023 emergence, is sharing clinical data from its revamped sickle cell gene editing program for the first time. The startup is giving a ...

Скрыть анонс
23:18 MedicalXpress.com AI starts writing acne prescriptions without a doctor's visit in one state

Utah has become the first state to let an artificial intelligence (AI) program prescribe medication without a doctor writing the prescription, starting with acne treatments.

Скрыть анонс
22:39 MedicalXpress.com New CRISPR proteins expand editing access to heart disease genes

Rice University's Han Xiao has used his AI-supported Sequence Display technology to expand the targeting abilities of CRISPR/Cas9. In a paper recently published in Nature Communications, Xiao evolved several variants of a compact Cas9 that could efficiently target stretches of DNA previously inaccessible for editing. The research included a proof-of-concept study in which the evolved Cas9s were successfully used to edit two genes found in coronary heart disease.

Скрыть анонс
22:18 MedicalXpress.com From green smoothies to stem‑cell supplements—online 'immune‑boosting' ideas may lead you astray

We all want a well-functioning immune system to help us fight invasive bacteria and viruses and recover faster from illness. Popular "immune-boosting" ideas, however, might be more of a hindrance than a help.

Скрыть анонс
22:18 MedicalXpress.com Key gene preserves lifelong supply of stem cells that make bone healing possible, study suggests

The action of a key gene is required to maintain a lifelong supply of stem cells that make bone healing possible, a new study finds.

Скрыть анонс
22:00 TechnologyReview.com Roundtables: Inside the Quest for Cognitive Immortality

Tuesday, November 17, 2026 In an effort to reach an elusive continuity of the self, some far-thinking technologists are working on ways to keep your brain going—even beyond death. Join science editor Mary Beth Griggs and senior editor for biomedicine Antonio Regalado for a conversation exploring possible paths to keep your mind going, including gradual…

Скрыть анонс
20:59 Bioengineer.org Cryo-EM reveals how a retrotransposon and CRISPR–Cas9 team up to insert genes

Cryo-electron microscopy structures of the zebra finch R2 retrotransposon, alone and bound to Cas9, reveal how target-primed reverse transcription initiates and guided the engineering of an enhanced STITCHR gene-integration system.

Скрыть анонс
20:40 Bioengineer.org Lung pressure predicts death risk in severe bronchiectasis patients awaiting transplants

A study of 56 end-stage non-CF bronchiectasis patients referred for lung transplantation evaluation found group 3 pulmonary hypertension in 73.2 percent and significantly higher mortality among those affected.

Скрыть анонс
20:26 Drugs.com AI Starts Writing Acne Prescriptions Without A Doctor’s Visit In One State

WEDNESDAY, Nov. 4, 2026 — Utah has become the first state to let an artificial intelligence (AI) program prescribe medication without a doctor writing the prescription, starting with acne treatments.New York City-based Nolla Health began offering...

Скрыть анонс
20:21 Bioengineer.org AI Reads Routine Thyroid Slides to Predict BRAF Mutation Before Surgery

An interpretable pathomics framework predicted BRAF V600E status in papillary thyroid carcinoma from routine Wright-stained cytology slides, reaching an AUC of 0.925 on pooled independent test data across two centers.

Скрыть анонс
20:21 Bioengineer.org Chemotherapy-Induced Senescence in Breast Cancer Cells Is Driven by Histone Lactylation

A multi-omics study shows that lactate produced by senescent breast cancer cells drives the SASP through histone H3 lactylation at inflammatory gene loci.

Скрыть анонс
19:40 Bioengineer.org AI Risk Scoring Cuts Unnecessary Kidney Surgery in Large Randomized Trial

A CT-based AI system reduced benign interventions among treated kidney lesions from 40.3 percent to 16.4 percent in a randomized implementation trial while improving radiologist accuracy and reading speed.

Скрыть анонс
19:40 Bioengineer.org GIS diagnostics map a no-greenfield path to regenerate aging Gulf districts

A GIS and AI-assisted planning framework tested on aging districts in Sharjah and Ajman proposes walkable street networks, land-bank reuse, parking consolidation and pocket greens without greenfield expansion.

Скрыть анонс
18:45 Bioengineer.org Breast and Leg Muscle Stem Cells in Chicks Follow Surprisingly Different Career Paths

Chick satellite cells from breast and leg muscles show opposite patterns of proliferation and differentiation when cultured under identical conditions, a new study finds.

Скрыть анонс
18:07 Labiotech.eu From gene editing to RNA therapies: The biotech trends to look out for at AHA Scientific Sessions 2026

We look at some of the key biotech developments, companies, and clinical data to watch at AHA Scientific Sessions 2026. The post From gene editing to RNA therapies: The biotech trends to look out for at AHA Scientific Sessions 2026 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Скрыть анонс
17:25 Nature.Com Clearing the way for a transformative stem-cell treatment for Parkinson’s disease

Скрыть анонс
17:19 Nature.com (news) Clearing the way for a transformative stem-cell treatment for Parkinson’s disease

Скрыть анонс
16:46 Правда.Ру Жировые ловушки и слабые мышцы: как body longevity ломает старую логику заботы о теле

Подход к уходу за телом в современной эстетической медицине претерпевает изменения. Если раньше основные усилия были сосредоточены на борьбе с лишними килограммами, то сегодня все чаще звучит термин body longevity. Это концепция, при которой фокус смещается с цифр на весах на сохранение качества тканей и функциональных ресурсов организма в долгосрочной перспективе. Тело как ресурс, а не объект для коррекции Сегодня специалисты призывают оценивать состояние организма комплексно. Важны не только объемы, но и состояние кожи, количество подкожно-жировой клетчатки, а также мышечная масса и сила. Такой подход подразумевает, что косметология не заменяет здоровый образ жизни, а лишь дополняет его, помогая справляться с задачами, которые невозможно решить только с помощью фитнеса или диет — например, с дряблостью кожи после похудения или локальными жировыми отложениями. Работа с разными слоями тканей Современные аппаратные методики позволяют точечно воздействовать на разные уровни: от дермы до

Скрыть анонс
15:30 Bioengineer.org Senescence-Like States in Sensory Neurons May Explain Why Pain Fails to Resolve

A new mini-review proposes that durable senescence-like states in dorsal root ganglion sensory neurons may help explain why pain persists after injury, while stressing the evidence remains a testable hypothesis rather than a proven cause.

Скрыть анонс
14:39 TomsHardware.com Disgruntled software developers start ambitious open-source revolt, using AI to clone common services — OccupySaaS AI-powered project wants to kick Auth0, Salesforce, and other pricy service-as-software to the curb

OccupySaaS AI-powered project wants to kick Auth0, Salesforce, and other pricy service-as-software to the curb

Скрыть анонс
14:28 Medscape.Com HIV Viral Suppression Does Not Erase Female Longevity Edge

Women with HIV who achieve sustained virologic suppression live longer than demographically similar men, a difference resembling the female longevity edge in the general population.

Скрыть анонс
13:52 Bioengineer.org Natural Compounds Show Promise Against Breast Cancer Stem Cells

A new review examines how plant-derived compounds such as polyphenols, flavonoids, alkaloids and isothiocyanates may target the breast cancer stem cells linked to recurrence, metastasis and treatment resistance.

Скрыть анонс
12:18 Arxiv.org Quantitative Biology El Agente F\'armaco: A Scalable AI Scientist for Drug Discovery

arXiv:2611.03832v1 Announce Type: cross Abstract: Computational drug discovery offers a growing range of tools for proposing and evaluating molecules, but combining them and deciding what to do next still requires substantial expert effort. Here, we introduce El Agente F\'armaco, an AI scientist that uses modern large language model (LLM) technology to turn discovery goals expressed in everyday language into complex, scalable computational screening workflows. The agentic harness selects scientific tools, reviews their results, and adjusts subsequent steps to the target and the user's objectives. Our approach centers on a shared scientific memory: F\'armaco Atlas, which stores molecules, structures, and results together with their provenance -- a record of how they were obtained. The agent uses targeted database queries to retrieve the evidence needed for each decision. A single request can launch calculations for an entire collection of molecules, without requiring a separate LLM

Скрыть анонс
09:35 GenEngNews.com FDA Sets May 1 PDUFA Action Date for uniQure’s Huntington’s Disease Gene Therapy

uniQure has aligned with the FDA on what the company calls key elements of the confirmatory study design: The study is being designed as a randomized, standard-of-care trial enrolling approximately 200 patients in a 2:1 ratio of ifezuntirgene inilparvovec to standard of care, with Total Functional Capacity (TFC) at 36 months serving as the primary endpoint. The post FDA Sets May 1 PDUFA Action Date for uniQure’s Huntington’s Disease Gene Therapy appeared first on GEN - Genetic Engineering and Biotechnology News.

Скрыть анонс
07:47 ScienceDaily.com Gene editing could replace a lifetime of medication, but there's a catch

A single gene-editing treatment could someday protect against heart disease, high cholesterol, and other common conditions for decades, potentially replacing lifelong medications. But scientists warn that permanently altering genes introduces risks that could take years to emerge, making long-term safety a critical challenge.

Скрыть анонс
07:34 TechMeme.com Pharmaceutical leaders are skeptical of claims that AI could cure most diseases within a decade; the US FDA has yet to clear any AI-designed biotech drugs (Xavier Martinez/Wall Street Journal)

Xavier Martinez / Wall Street Journal: Pharmaceutical leaders are skeptical of claims that AI could cure most diseases within a decade; the US FDA has yet to clear any AI-designed biotech drugs  —  No drug designed by artificial intelligence has won FDA clearance, and pharma leaders say biology is the obstacle

Скрыть анонс
06:07 MedicalDaily.com Huntington's Gene Therapy AMT-130 Gets FDA Priority Review and a May 2027 Decision Date, Advisory Panel Planned

The FDA accepted uniQure's AMT-130 application for Huntington's disease, granted priority review, and set a May 1, 2027, target decision date while approval remains uncertain.

Скрыть анонс
05:45 News-Medical.Net Engineered beneficial bacteria reduce bloodstream infections after stem cell transplants

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, and collaborators have pioneered a new approach to preventing dangerous bloodstream infections in patients receiving donor stem cell transplants for blood cancers.

Скрыть анонс
05:12 Phys.org Lab-grown neurons retain features of embryonic development

Scientists from Skoltech, together with colleagues from the Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Lomonosov Moscow State University and other organizations, conducted a comparative study of the 3D genome organization in neurons derived from induced pluripotent stem cells and in neurons of the adult human brain. The authors collected and processed more than 300 3D genome maps covering 62 human samples and 34 mouse samples, including data on embryonic stem cells, induced pluripotent stem cells, neural progenitors, fetal and postmortem neurons, as well as neurons differentiated in vitro.

Скрыть анонс
03:25 Phys.org Semiautomated platform delivers consistent batches of extracellular vesicles for potential regenerative therapies

A study led by researchers from the Germans Trias i Pujol Research Institute (IGTP) and the Blood and Tissue Bank (BST) has developed and validated a manufacturing platform for extracellular vesicles that meets pharmaceutical quality requirements, marking a key step toward their clinical application.

Скрыть анонс
02:47 Bioengineer.org Basiliximab induction linked to sustained renal recovery after liver transplantation in high-risk recipients

A retrospective Australian cohort study of 405 liver transplant recipients found that basiliximab induction was associated with early and sustained improvement in adjusted serum creatinine and greater renal dysfunction resolution at 12 and 24 months, without differences in rejection, graft survival or patient survival.

Скрыть анонс
02:47 Bioengineer.org Antihistamine-inspired lipid nanoparticles ferry mRNA and gene-editing tools into the brain

Researchers engineered lipid nanoparticles around the antihistamine hydroxyzine, achieving brain delivery of mRNA, CRISPR components and a radioprotective interleukin in animal models.

Скрыть анонс
02:29 Bioengineer.org Kidney transplant recipients hold on to RSV immunity despite immunosuppression

A Dutch study finds that kidney transplant recipients maintain RSV-specific antibodies and memory T cells comparable to healthy controls despite long-term immunosuppressive treatment.

Скрыть анонс
00:57 Endpts.com Ultragenyx to lay off 20% of employees, scrap a Wilson disease gene therapy

After a whirlwind third quarter that saw two FDA approvals but a major setback in Angelman syndrome, Ultragenyx is laying off staff for the second time this year. The California biopharma

Скрыть анонс
00:11 TheVerge.com Those Jeff Bezos hair transplant photos are very fake

These edits of Jason Statham (left) and Jeff Bezos are a bit jarring, but that’s sort of the point. | Image: The Verge Amazon founder Jeff Bezos and actor Jason Statham have a distinctive feature in common: They're both famously bald, and that definitely hasn't changed in the last few days. However, there are some images of the two men circulating around X, Threads, and Bluesky in which they both have substantially more hair than their usual shaved look, which in Bezos' case appears to be very freshly transplanted. It's all just photo editing fakery, AI or otherwise. It's unclear how viral these posts are, but they're prevalent enough that a few members of the Verge team have encountered them in their social media feeds. Some people who shared them claimed … Read the full story at The Verge.

Скрыть анонс
Первая← Предыдущая12345678910Предыдущая →